What are you buying today?

[dipod]

NVO. Pays a good dividend. And should continue to grow earnings at an acceptable rate with their new drug pipeline (cagrisema, amycretin). Ozempic also continues to get one more new indication after the other (kind of how ACE-Inhibitors are used to treat kidney disease in diabetics that may not necessarily have hypertension). 

 

[Lance]

Bought back most of the BTI calls I recently sold and made a small add.

 

Thanks

Lance

[lnofeisone]

CNC

[Spekulatius]

2 hours ago, dipod said:

NVO. Pays a good dividend. And should continue to grow earnings at an acceptable rate with their new drug pipeline (cagrisema, amycretin). Ozempic also continues to get one more new indication after the other (kind of how ACE-Inhibitors are used to treat kidney disease in diabetics that may not necessarily have hypertension). 

 

Tariffs could become a big issue once the Eye of Sauron looks at Denmark and NVO.

[Parsad]

5 hours ago, Spekulatius said:

Tariffs could become a big issue once the Eye of Sauron looks at Denmark and NVO.

 

Spek, please try to use "current administration" next time.  What you said can be deemed to be inflammatory or antagonistic, which only opens the thread to further political comments.  Cheers!

[Lazarus]

On 2/11/2025 at 11:26 AM, Cod Liver Oil said:

Added to Crox. All the shoe companies seem to be tariff casualties. I like Crox at 90 and NKE at 70. Skechers and Deck getting tarred with the same brush. Thank you, Orange Man!!! 

Cod, please try to use "President Trump!!!" next time.  What you said can be deemed to be inflammatory or antagonistic, which only opens the thread to further political comments. Cheers!

[Parsad]

2 hours ago, Lazarus said:

Cod, please try to use "President Trump!!!" next time.  What you said can be deemed to be inflammatory or antagonistic, which only opens the thread to further political comments. Cheers!

 

Yup, you too Cod!  But he doesn't have to use "President Trump".  He can also just say "current administration." 

 

Cheers!

 

 

[DooDiligence]

You gotta write the whole username or it could be construed as inflammatory.

 

Nobody wants an enflamed testicle.

 

 

: )

Edited February 14, 2025 by DooDiligence

[John Hjorth]

15 hours ago, Spekulatius said:

Tariffs could become a big issue once ... .... looks at Denmark and NVO.

 

CEO Lars Fruergaard Jørgensen was specifically asked about it in an interview a few days ago. [I think it must have been in connection with the release last week of the Annual Report for 2024, which I'm still digesting and chewing on.] Mr. Jørgensen said he considered it manageable for the company, because the company already has production and production capacity in the US. The answer was phrased in a way, that I perceived it as not just a triviality, though.

 

- - - o 0 o - - -

 

Edit :

 

Here is the interview : 

 

Bloomberg - Industries - Health [February 5^th 2025] : Novo Sees Ozempic Boom Prompting Another Sales Surge.

Edited February 14, 2025 by John Hjorth

[John Hjorth]

18 hours ago, dipod said:

NVO. ... 

 

Welcome in the arena , @dipod 

 

[Luke]

28 minutes ago, John Hjorth said:

 

Welcome in the arena , @dipod 

 

Its a very nice company and they have access to a great talent pool...i own a tracker now too and is a joy to follow what breakthroughs they will come up with in the future.

[Saluki]

I picked up a few shares of ISSC and hope to add a little each day as I keep selling off some other stuff.  I got lucky a couple of days ago and picked up a few shares of POWW cumulative preferred when it dropped 10% for no reason (sloppy seller? fat finger?).  I had other limit orders in for it at different prices, but none got filled 

 

Adding a tiny bit of VG each day.  I'm glad I didn't go big all at once, but sometimes the opportunity passes quickly like Fairfax after the short report.  

[Spekulatius]

Starter in HII (more ships against  China thesis) and add to CACI (Doge inspired meltdown of a compounder).

[Spekulatius]

On 2/14/2025 at 4:19 AM, John Hjorth said:

 

CEO Lars Fruergaard Jørgensen was specifically asked about it in an interview a few days ago. [I think it must have been in connection with the release last week of the Annual Report for 2024, which I'm still digesting and chewing on.] Mr. Jørgensen said he considered it manageable for the company, because the company already has production and production capacity in the US. The answer was phrased in a way, that I perceived it as not just a triviality, though.

 

- - - o 0 o - - -

 

Edit :

 

Here is the interview : 

 

Bloomberg - Industries - Health [February 5^th 2025] : Novo Sees Ozempic Boom Prompting Another Sales Surge.

I checked on this, NVO revenue are 57.5% (167/290B DKK) in the US, but the US manufacturing site is only the 4th largest site of NVO, which to me indicates they are importing a lot into the US. This makes them vulnerable to tariffs. Trump has specifically mentioned medicine/drug imports a few times as well. Also, NVO is Danish and there is this Greenland thing going on as you well know.

 

I expect we will hear more about this. European tariffs are on the menu, I think by April 1st and I don’t  think it’s going to be a joke.

Edited February 15, 2025 by Spekulatius

[villainx]

On 12/21/2024 at 10:56 AM, Spekulatius said:

It’s basically a uniform laundry/ consumables business similar to VSTS or Cintas

 

How has Cintas have such an outstanding absolute and relative to peer track record?  Just heard about Cintas on Liberty's recent podcast and had to check out the company.

 

 

edit: a bit of it is - quality driven? -multiple expansion.

Edited February 15, 2025 by villainx

[mananainvesting]

Added to $ACIC

[Spekulatius]

13 hours ago, villainx said:

 

How has Cintas have such an outstanding absolute and relative to peer track record?  Just heard about Cintas on Liberty's recent podcast and had to check out the company.

 

 

edit: a bit of it is - quality driven? -multiple expansion.

Definitely multiple expansion because they outperformed the competition for quite some time.

[villainx]

44 minutes ago, Spekulatius said:

Definitely multiple expansion because they outperformed the competition for quite some time.

 

On a personal note, I really feel like I'm living in a dream/simulation reality.  It's like, there are these supposedly great compounders out there, constellation software, waste management, transdigm, costco, etc., and then I listen to a podcast, and what the heck, there's another great compounder that isn't some new flash in the pan company, but - like Cintas - has actually been around for decades and decades.

 

Always something new or new to learn.  

[gfp]

On 2/4/2025 at 9:16 AM, Blake Hampton said:

Just bought a 3-year subscription to Value Line.

 

What happened to Blake Hampton?  Did he buy a value line subscription and disappear burying his nose into undervalued stock after undervalued stock?  Or has he disappeared from the forum entirely!?

 

Has the unsustainable government finance situation claimed another victim?!

[CorpRaider]

I wonder if he got the sweet sweet paper version.  Jealous.

[Hsmpanl]

3 hours ago, CorpRaider said:

I wonder if he got the sweet sweet paper version.  Jealous.

Library online subscription and a printer at work is the shit

Edited February 15, 2025 by Hsmpanl

[Lance]

Sold calls on M and T.

 

Added to BTI and IBIT.

 

Thanks

Lance

[longlake95]

More CNC and ATRL 

[Ross812]

increased my DFIN position by 25%

[Dinar]

I bought Fuso Chemical - thank you @Spekulatius, yesterday evening.